Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.36 -0.03 (-1.26%)
At close: Oct 21, 2026 · 4:00 PM EDT

Zentalis Pharmaceuticals (ZNTL) EBIT Margin (2024)

Updated

Zentalis Pharmaceuticals' EBIT Margin was -185.55% in Q4 2024.

Analysis

Zentalis Pharmaceuticals (ZNTL) EBIT Margin (2024) Analysis & Trends

For FY2024, EBIT Margin at Zentalis Pharmaceuticals came in at -283.57%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Zentalis Pharmaceuticals 167.62 Mn -742.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -185.55%
Mar 31, 2024 -61.06%
API Access

Zentalis Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZNTL&period=max&api_key=YOUR_API_KEY